II. Indications
- Thrombus Prophylaxis (e.g. DVT Prophylaxis after hip surgery)
- Unstable Angina
- Percutaneous Coronary Intervention (PCI)
- Heparin-Induced Thrombocytopenia
- Atrial Fibrillation
III. Dosing: Hirudins (bivalent peptide derivatives from Salivary Gland of medicinal leaches)
- Lepirudan (Refludan)- See other references for dosing
 
- 
                          Bivalirudin (Angiomax)- Used in Unstable Angina if Heparin contraindicated
- Coadminister with Aspirin
- Initial: 0.75 mg/kg IV bolus
- Later: 1.75 mg/kg/hour for 4 hours
- Maintenance: 0.2 mg/kg/hour for up to 20 hours
 
- 
                          Desirudin (Ipravask)- DVT Prophylaxis: 15 mg SQ q12 hours after hip surgery
 
IV. Dosing: Non-Hirudans (Univalent agents)
- 
                          Dabigatran (Pradaxa)- See Dabigatran
 
- 
                          Ximelagatran (Exanta, Exarta)- No longer available in United States due to hepatotoxicity
 
- 
                          Argatroban (Acova)- Initial: 2 mcg/kg/minute
- Maintenance: Adjusted per PTT
 
V. Pharmacokinetics
- Clearance- Renal Clearance for Hirudins
- Hepatic Clearance for L-Arginine derivatives
 
VI. Precautions
- 
                          Allergic Reaction
                          - Serious Allergic Reactions including Anaphylaxis may occur with Hirudins
- Highest risk on Hirudin re-exposure or in GFR <30 ml/min
 
- Bleeding complications- Epidural Hematoma- High risk if Lumbar Puncture performed while on Direct Thrombin Inhibitors
 
 
- Epidural Hematoma
- No antidote for bleeding except for Dabigatran (all recommendations per expert opinion)- Dabigatran (Pradaxa) has a specific antidote (Praxbind)
- Stop offending agent (most have short Half-Life such as 12-14 hours for Dabigatran)
- Bleeding unlikely due to Direct Thrombin Inhibitor if aPTT <37 seconds and Thrombin Time <25 seconds
- Consider Activated Charcoal if presenting within 2 hours of suspected Overdose ingestion
- Dialysis is unlikely to be beneficial- Logistics of placing large bore filtered catheters in actively bleeding, coagulopathic patients
 
- Life threatening bleeding - reversal agents
 
